Location · Georgia
Clinical trials recruiting in Georgia
792 recruiting studies have at least one site in Georgia; 175 accept healthy volunteers. Studies that need a specific condition are included too, so check each listing.
Want the research companies that run paid Phase 1 studies for healthy volunteers? Paid clinical trial companies in Georgia.
792 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
More recruiting studies (pay not posted)
- RecruitingHealthy volunteersPhase 2
A Study to Learn About mRNA Vaccines Against Influenza in Adults
Pfizer
- Location
- Stockbridge, GA + 14 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 4
A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
ModernaTX, Inc.
- Location
- Atlanta, GA + 5 other US sites
- Eligibility basics
- Ages 6 mo+
- RecruitingHealthy volunteers
Caris Biorepository Research Protocol
Caris Science, Inc.
- Location
- Albany, GA + 37 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Adela, Inc
- Location
- Gainesville, GA + 15 other US sites
- Eligibility basics
- Ages 40+
- RecruitingHealthy volunteers
Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens
SightGlass Vision, Inc.
- Location
- Marietta, GA + 13 other US sites
- Eligibility basics
- Ages 6–8
- RecruitingHealthy volunteers
Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm Infants
Thrive Neuromedical, LLC
- Location
- Atlanta, GA
- Eligibility basics
- Ages 7 mo–8 mo
- RecruitingHealthy volunteers
InSpace Accelerated Rehabilitation Study
Stryker Endoscopy
- Location
- Atlanta, GA + 10 other US sites
- Eligibility basics
- Ages 65+
- RecruitingHealthy volunteersPhase 3
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
Reviva Pharmaceuticals
- Location
- Atlanta, GA + 16 other US sites
- Eligibility basics
- Ages 18–65
- Recruiting
Assessment of CCM in HF With Higher Ejection Fraction
Impulse Dynamics
- Location
- Gainesville, GA + 64 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
TG Therapeutics, Inc.
- Location
- Atlanta, GA + 35 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Hoffmann-La Roche
- Location
- Athens, GA + 121 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Hoffmann-La Roche
- Location
- Athens, GA + 112 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Merck Sharp & Dohme LLC
- Location
- Atlanta, GA + 70 other US sites
- Eligibility basics
- Ages 16–80
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
Bristol-Myers Squibb
- Location
- Atlanta, GA + 18 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Takeda
- Location
- Columbus, GA + 42 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular…
AbbVie
- Location
- Augusta, GA + 54 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 3
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Sanofi
- Location
- Atlanta, GA + 118 other US sites
- Eligibility basics
- Ages 16–80
- RecruitingPhase 3
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Sanofi
- Location
- Adairsville, GA + 70 other US sites
- Eligibility basics
- Ages 40–80
- RecruitingPhase 3
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Novartis Pharmaceuticals
- Location
- Atlanta, GA + 19 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
Merck Sharp & Dohme LLC
- Location
- Macon, GA + 10 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Trial to Evaluate the Safety, Tolerability and Efficacy of AIC263029 in Kidney Transplant Recipients With BKV Infection
AiCuris Anti-infective Cures AG
- Location
- Atlanta, GA + 6 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation
Boston Scientific Corporation
- Location
- Atlanta, GA + 9 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Amgen
- Location
- Canton, GA + 51 other US sites
- Eligibility basics
- Ages 18–99
- RecruitingPhase 3
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
Definium Therapeutics US, Inc.
- Location
- Atlanta, GA + 22 other US sites
- Eligibility basics
- Ages 18–74